Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Jude Fitzgibbon, Sameena Iqbal et al.|Nature Genetics|2015Cited by 213
Oncogenic Rag GTPase signalling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTORAna Ortega-Molina, Alejo Efeyan, Nerea Deleyto-Seldas et al.|Nature Metabolism|2019Cited by 66
Erratum: Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphomaJessica Okosun, Jude Fitzgibbon, Rachel L. Wolfson et al.|Nature Genetics|2016Cited by 2
<i>CREBBP</i> histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphomaEmil Kumar, Jessica Okosun, Koorosh Korfi et al.|British Journal of Haematology|2024Cited by 1
PF513 MUTATIONS AFFECTING THE CREBBP HAT DOMAIN PREDICT RESPONSE TO MTOR INHIBITORS EVEROLIMUS AND TEMSIROLIMUS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMAEmil Kumar, Jude Fitzgibbon, Koorosh Korfi et al.|HemaSphere|2019Cited by 0